JP7425092B2 - 抗線維化剤、及び抗線維化作用を有する細胞外小胞の製造方法 - Google Patents

抗線維化剤、及び抗線維化作用を有する細胞外小胞の製造方法 Download PDF

Info

Publication number
JP7425092B2
JP7425092B2 JP2021571238A JP2021571238A JP7425092B2 JP 7425092 B2 JP7425092 B2 JP 7425092B2 JP 2021571238 A JP2021571238 A JP 2021571238A JP 2021571238 A JP2021571238 A JP 2021571238A JP 7425092 B2 JP7425092 B2 JP 7425092B2
Authority
JP
Japan
Prior art keywords
extracellular vesicles
derived
affinity
solution
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2021571238A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2021145395A5 (cg-RX-API-DMAC7.html
JPWO2021145395A1 (cg-RX-API-DMAC7.html
Inventor
昌之 山根
貴将 石止
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujifilm Corp
Original Assignee
Fujifilm Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=76864638&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JP7425092(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Fujifilm Corp filed Critical Fujifilm Corp
Publication of JPWO2021145395A1 publication Critical patent/JPWO2021145395A1/ja
Publication of JPWO2021145395A5 publication Critical patent/JPWO2021145395A5/ja
Application granted granted Critical
Publication of JP7425092B2 publication Critical patent/JP7425092B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0667—Adipose-derived stem cells [ADSC]; Adipose stromal stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0668—Mesenchymal stem cells from other natural sources

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
JP2021571238A 2020-01-15 2021-01-14 抗線維化剤、及び抗線維化作用を有する細胞外小胞の製造方法 Active JP7425092B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2020004765 2020-01-15
JP2020004765 2020-01-15
PCT/JP2021/001131 WO2021145395A1 (ja) 2020-01-15 2021-01-14 抗線維化剤、及び抗線維化作用を有する細胞外小胞の製造方法

Publications (3)

Publication Number Publication Date
JPWO2021145395A1 JPWO2021145395A1 (cg-RX-API-DMAC7.html) 2021-07-22
JPWO2021145395A5 JPWO2021145395A5 (cg-RX-API-DMAC7.html) 2022-09-08
JP7425092B2 true JP7425092B2 (ja) 2024-01-30

Family

ID=76864638

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021571238A Active JP7425092B2 (ja) 2020-01-15 2021-01-14 抗線維化剤、及び抗線維化作用を有する細胞外小胞の製造方法

Country Status (5)

Country Link
US (1) US20220362290A1 (cg-RX-API-DMAC7.html)
EP (1) EP4091617A4 (cg-RX-API-DMAC7.html)
JP (1) JP7425092B2 (cg-RX-API-DMAC7.html)
CN (1) CN115361956A (cg-RX-API-DMAC7.html)
WO (1) WO2021145395A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022080461A1 (ja) * 2020-10-16 2022-04-21 富士フイルム和光純薬株式会社 細胞外小胞の産生用培地、培地キット、添加剤及び細胞外小胞の産生方法
CN114306278A (zh) * 2021-12-30 2022-04-12 上海纳米技术及应用国家工程研究中心有限公司 一种EV装载CPP-siRNA纳米颗粒的制备方法及其产品和应用
CN117899007A (zh) * 2024-01-22 2024-04-19 华北理工大学 一种负载ADSCs来源外泌体的水凝胶及其制备方法和应用
CN119157906B (zh) * 2024-09-30 2025-06-24 广州飞来爱生命科技有限公司 一种脐带间充质干细胞制剂及其在治疗肝脏疾病的用途

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016088689A1 (ja) 2014-12-05 2016-06-09 和光純薬工業株式会社 Timタンパク質結合担体、当該担体を用いた細胞外膜小胞及びウイルスの取得方法、除去方法、検出方法並びに当該担体を含むキット

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6035263A (ja) 1983-08-05 1985-02-23 Wako Pure Chem Ind Ltd 不溶性担体に固定化された免疫活性物質の安定化法及び該物質を構成単位として含む生理活性物質測定用試薬
US5200471A (en) 1990-11-05 1993-04-06 Minnesota Mining And Manufacturing Company Biomolecules covalently immobilized with a high bound specific biological activity and method of preparing same
US8658374B2 (en) * 2002-02-28 2014-02-25 Microsens Biphage Limited Binding of aggregated forms of proteins
WO2010107068A1 (ja) * 2009-03-17 2010-09-23 和光純薬工業株式会社 β-グルカンの測定方法及びそれに用いられるβ-グルカン結合性蛋白質
WO2012039395A1 (ja) 2010-09-24 2012-03-29 和光純薬工業株式会社 small RNAの取得方法
JP2016088689A (ja) 2014-11-05 2016-05-23 セイコーエプソン株式会社 媒体保持具、媒体装填装置、記録装置
KR101844519B1 (ko) * 2016-08-05 2018-04-02 한국생명공학연구원 섬유증 질환 모델의 제조방법 및 섬유증 질환 모델의 용도
CN109891236A (zh) * 2016-10-13 2019-06-14 合同会社明乐康中央研究所 回收胞外囊泡的方法
CA3099042A1 (en) * 2018-05-09 2019-11-14 Children's Medical Center Corporation Mesenchymal stromal cell exosome -treated monocytes and uses thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016088689A1 (ja) 2014-12-05 2016-06-09 和光純薬工業株式会社 Timタンパク質結合担体、当該担体を用いた細胞外膜小胞及びウイルスの取得方法、除去方法、検出方法並びに当該担体を含むキット

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
FERGUSON, S. W., et al.,The microRNA regulatory landscape of MSC-derived exosomes: a systems view,Scinetific Reports,2018年,Vol.8, Article No.1419,pp.1-12,DOI:10.1038/s41598-018-19581-x
NAKAI, W., et al.,A novel affinity-based method for the isolation of highly purified extracellular vesicles,Scientific Reports,2016年,Vol.6, Article No.33935,pp.1-11,DOI: 10.1038/srep33935
OHARA, M., et al.,Extracellular Vesicles from Amnion-Derived Mesenchymal Stem Cells Ameliorate Hepatic Inflammation and Fibrosis in Rats,Stem Cells International,2018年,Vol.2018, Article ID 3212643,pp.1-15,https://doi.org/10.1155/2018/3212643
PHINNEY, D. G., et al.,Concise Review: MSC-Derived Exosomes for Cell-Free Therapy,Stem Cells,2017年,Vol.35, No.4,pp.851-858,http://dx.doi.org/10.1002/stem.2575
TOLOMEO, A. M., et al.,Annexin a5(An5)-bound extracellular vesicles (EVs) from mesenchymal stromal cells (MSCs) show enhanced and specific antiinflammatory effects,J. Extracellular Vesicles,2018年,Vol.7, Supplement 1,p.10,DOI:10.1080/20013078.2018.1461450,ISSN: 2001-3078
山根 昌之 ほか,PSアフィニティー法が実現した高活性なMSC由来エクソソームの精製 -エクソソーム再生医療における全く新たな戦略の提案-,和光純薬時報,2020年10月15日,Vol.88, No.4,pp.10-11

Also Published As

Publication number Publication date
US20220362290A1 (en) 2022-11-17
EP4091617A1 (en) 2022-11-23
EP4091617A4 (en) 2023-08-09
CN115361956A (zh) 2022-11-18
WO2021145395A1 (ja) 2021-07-22
JPWO2021145395A1 (cg-RX-API-DMAC7.html) 2021-07-22

Similar Documents

Publication Publication Date Title
US20230364150A1 (en) Method for isolation and purification of microvesicles from cell culture supernatants and biological fluids
US20220362290A1 (en) Anti-fibrosis agent and method of producing extracellular vesicle having anti-fibrosis action
Li et al. Exosomes derived from mesenchymal stem cells attenuate inflammation and demyelination of the central nervous system in EAE rats by regulating the polarization of microglia
US9877989B2 (en) Use of preparations comprising exosomes derived from mesenchymal stem cells (MSCs) in the prevention and therapy of inflammatory conditions
AU2018335788B2 (en) Methods and compositions for the treatment of epidermolysis bullosa
JP2019517488A (ja) 医学に使用するためのヒト血小板溶解物由来細胞外小胞
JP2023538109A (ja) 骨髄由来間葉系幹細胞からの微小胞を使用する処置の組成物及び方法
Öztürk et al. Immune regulation is more effective in the U937 inflammation model with mesenchymal stem cell extracellular vesicles stimulated by pro-inflammatory cytokines
US12533381B2 (en) Angiogenesis agent and method of producing extracellular vesicle having angiogenesis action
JP7461382B2 (ja) 抗炎症剤、及び抗炎症作用を有する細胞外小胞の製造方法
WO2021200299A1 (ja) 細胞老化抑制剤、生体組織修復促進剤、遺伝子発現調節剤及び製造方法
Munshi et al. Comprehensive Proteomic Analysis and Characterization of Human Bone Marrow Mesenchymal Stem/Stromal Derived Extracellular Vesicles
Bharat et al. Hepatic Stellate Cell Exosomes Resolve Fibrosis in Mice Livers via Enriched Metabolic and Regenerative Signaling Molecules
HK40032447A (en) Method for isolation and purification of microvesicles from cell culture supernatants and biological fluids
HK1263117A1 (en) Human platelet lysate derived extracellular vesicles for use in medicine
Tam Investigating the Effects of Autophagic-Lysosomal Modulation on Extracellular Vesicles Derived from Neuronal, Astrocytic, and Microglial Cell Lines

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220713

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20220713

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230523

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20230623

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230921

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20231226

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20240118

R150 Certificate of patent or registration of utility model

Ref document number: 7425092

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R157 Certificate of patent or utility model (correction)

Free format text: JAPANESE INTERMEDIATE CODE: R157

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313111

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350